EXUMA
Live / Registered — Registered (as of 05 May 2026)
What this means for you
Registered since 05 May 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 05 May 2032: the §8 declaration of use).
Record
- Serial number
- 97544808
- Registration number
- 8243286
- Mark type
- Word mark
- Filed
- 11 Aug 2022
- Published for opposition
- 12 Mar 2024
- Registered
- 05 May 2026
- Next maintenance filing
- §8 declaration of use, due by 05 May 2032 (grace period to 05 Nov 2032)
- Attorney of record
- Alison M. Caless
Goods and services
- Class 005 — Pharmaceuticals: Medicines for human purposes in the nature of pharmaceutical preparations for gene and cell therapy, immunotherapy and the treatment of cancer, immunological diseases and disorders, genetic disorders, rare diseases, and infectious diseases; biological preparations for medical treatment of cancer, immunological diseases and disorders, genetic disorders, rare diseases, gene and cell therapy, and infectious diseases for humans and animals; medical biological tissue cultures and viruses for the prevention and treatment of cancer for humans and animals; drug products in the nature of pharmaceutical preparations for immunotherapy and the treatment of cancer, immunological diseases and disorders, genetic disorders, rare diseases, and infectious diseases for humans and animals
- Class 040 — Treatment of materials: Custom manufacturing of medical products in the nature of biological tissue, blood, viruses, and cells; custom manufacturing of pharmaceutical preparations for immunotherapy, including gene therapy, CAR T cell therapy, and cell therapy; custom manufacturing of biological preparations for the treatment of cancer
- Class 042 — Scientific and technological services: Bacteriological research; biological research; medical and scientific research, namely, conducting clinical trials for others; medical research; virological research; medical laboratory services; scientific research; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs, namely, processing blood to isolate leukocytes for the creation of immunotherapies; scientific and medical research and development of pharmaceutical preparations and drugs; computer programming in relation to medicine and medical research; research in the field of stem cells
Owner
- Exuma Biotech Corp., West Palm Beach, FL, US
- Exuma Biotech Corp., West Palm Beach, FL, US
- Exuma Biotech Corp., West Palm Beach, FL, US
Prosecution history
- 05 May 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 May 2026 — REGISTERED-PRINCIPAL REGISTER
- 15 Apr 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 Apr 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Apr 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 07 Nov 2025 — USE AMENDMENT FILED
- 07 Nov 2025 — TEAS STATEMENT OF USE RECEIVED
- 07 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 May 2025 — SOU EXTENSION 2 GRANTED
- 06 May 2025 — SOU EXTENSION 2 FILED
- 06 May 2025 — SOU TEAS EXTENSION RECEIVED
- 06 Nov 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Nov 2024 — SOU EXTENSION 1 GRANTED
- 06 Nov 2024 — SOU EXTENSION 1 FILED
- 06 Nov 2024 — SOU TEAS EXTENSION RECEIVED